These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23273604)

  • 21. Acquired genomic copy number aberrations in CLL.
    Ouillette P; Malek S
    Adv Exp Med Biol; 2013; 792():47-86. PubMed ID: 24014292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
    González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
    Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
    Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
    Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
    Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
    Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia.
    Zhang L; Znoyko I; Costa LJ; Conlin LK; Daber RD; Self SE; Wolff DJ
    Cancer Genet; 2011 Dec; 204(12):654-65. PubMed ID: 22285017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.
    Gunn SR; Mohammed MS; Gorre ME; Cotter PD; Kim J; Bahler DW; Preobrazhensky SN; Higgins RA; Bolla AR; Ismail SH; de Jong D; Eldering E; van Oers MH; Mellink CH; Keating MJ; Schlette EJ; Abruzzo LV; Robetorye RS
    J Mol Diagn; 2008 Sep; 10(5):442-51. PubMed ID: 18687794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panel.
    Urbankova H; Papajik T; Plachy R; Holzerova M; Balcarkova J; Divoka M; Prochazka V; Pikalova Z; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):56-64. PubMed ID: 23073527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
    Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
    Malek SN
    Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined somatic mutation and copy number analysis in the survival of familial CLL.
    Zhou W; Goldin L; Wang M; McMaster ML; Jones K; Burdett L; Chanock SJ; Yeager M; Dean M; Caporaso NE
    Br J Haematol; 2018 Jun; 181(5):604-613. PubMed ID: 29687880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
    Wang H; Xu H; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
    Kujawski L; Ouillette P; Erba H; Saddler C; Jakubowiak A; Kaminski M; Shedden K; Malek SN
    Blood; 2008 Sep; 112(5):1993-2003. PubMed ID: 18436738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?
    Puiggros A; Puigdecanet E; Salido M; Ferrer A; Abella E; Gimeno E; Nonell L; Herranz MJ; Galván AB; Rodríguez-Rivera M; Melero C; Pairet S; Bellosillo B; Serrano S; Florensa L; Solé F; Espinet B
    Leuk Lymphoma; 2013 May; 54(5):986-95. PubMed ID: 22994157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.